Search This Blog

Wednesday, May 3, 2023

Sutro, Mersana jump after Immunogen data for ovarian cancer therapy

 Sutro Biopharma (STRO) and Mersana Therapeutics (MRSN) gained Wednesday after ImmunoGen (IMGN) posted positive data for its ovarian cancer therapy.

https://seekingalpha.com/news/3964512-sutro-stock-mersana-stock-jump-immunogen-ovarian-cancer-data

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.